EPS Creative Health Technology Group (HKSE:03860) Debt-to-EBITDA : 22.93 (As of Sep. 2023)

EPS Creative Health Technology Group Debt-to-EBITDA Chart

EPS Creative Health Technology Group Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Debt-to-EBITDA		Get a 7-Day Free Trial				0.01	0.11	0.23	-0.33	-0.07

EPS Creative Health Technology Group Semi-Annual Data
	Mar15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-EBITDA	Get a 7-Day Free Trial												-0.09	-0.17	-0.12	-0.06	22.93

Competitive Comparison of EPS Creative Health Technology Group's Debt-to-EBITDA

For the Apparel Retail subindustry, EPS Creative Health Technology Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EPS Creative Health Technology Group's Debt-to-EBITDA Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, EPS Creative Health Technology Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where EPS Creative Health Technology Group's Debt-to-EBITDA falls into.

EPS Creative Health Technology Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

EPS Creative Health Technology Group's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

EPS Creative Health Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.

EPS Creative Health Technology Group  (HKSE:03860) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

EPS Creative Health Technology Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of EPS Creative Health Technology Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

EPS Creative Health Technology Group (HKSE:03860) Business Description